Honglin Yan

1.0k total citations
35 papers, 756 citations indexed

About

Honglin Yan is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Honglin Yan has authored 35 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Honglin Yan's work include Erythrocyte Function and Pathophysiology (3 papers), MicroRNA in disease regulation (3 papers) and Ferroptosis and cancer prognosis (3 papers). Honglin Yan is often cited by papers focused on Erythrocyte Function and Pathophysiology (3 papers), MicroRNA in disease regulation (3 papers) and Ferroptosis and cancer prognosis (3 papers). Honglin Yan collaborates with scholars based in China and United States. Honglin Yan's co-authors include Jingping Yuan, Jie Rao, Likun Gao, Wenxian Huang, Lina Zhao, Dandan Yan, Juan Wu, Jingping Yuan, Chuang Chen and Bin Luo and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Neuroscience.

In The Last Decade

Honglin Yan

34 papers receiving 752 citations

Peers

Honglin Yan
Minseob Eom South Korea
Ahmad Hanif United States
Honglin Yan
Citations per year, relative to Honglin Yan Honglin Yan (= 1×) peers Huiling Li

Countries citing papers authored by Honglin Yan

Since Specialization
Citations

This map shows the geographic impact of Honglin Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honglin Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honglin Yan more than expected).

Fields of papers citing papers by Honglin Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honglin Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honglin Yan. The network helps show where Honglin Yan may publish in the future.

Co-authorship network of co-authors of Honglin Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Honglin Yan. A scholar is included among the top collaborators of Honglin Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honglin Yan. Honglin Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Jian, Honglin Yan, Zhongjia Huang, et al.. (2025). Plant polysaccharides with anti-aging effects and mechanism in evaluation model Caenorhabditis elegans. International Journal of Biological Macromolecules. 308(Pt 3). 142268–142268. 1 indexed citations
2.
Xue, Hao, et al.. (2025). A review of the pathogenesis of mitochondria in breast cancer and progress of targeting mitochondria for breast cancer treatment. Journal of Translational Medicine. 23(1). 70–70. 3 indexed citations
3.
Rao, Jie, et al.. (2024). Single-Cell RNA-Sequencing: Opening New Horizons for Breast Cancer Research. International Journal of Molecular Sciences. 25(17). 9482–9482. 4 indexed citations
4.
Zhao, Lina, et al.. (2024). CIC::NUTM1 sarcomas occurred in soft tissues of upper limbs : a rare case report and literature review. Diagnostic Pathology. 19(1). 76–76. 1 indexed citations
5.
Rao, Jie, et al.. (2024). Case report: Innovative treatment for one metastatic thyroid-like follicular carcinoma of the kidney with ATM and POLE mutations. Frontiers in Oncology. 14. 1352865–1352865. 1 indexed citations
6.
Yan, Honglin, et al.. (2023). MiR-133a/CD47 axis is a novel prognostic biomarker to promote triple negative breast cancer progression. Pathology - Research and Practice. 244. 154400–154400.
7.
Yuan, Jingping, Yabing Huang, Honglin Yan, et al.. (2023). Nomograms for predicting overall survival and cancer-specific survival of patients with stage Ⅳ renal cell carcinoma: A SEER population-based study. SHILAP Revista de lepidopterología. 2(1). e9130014–e9130014. 1 indexed citations
8.
Yan, Dandan, et al.. (2022). Endocrine-disrupting chemicals and the risk of gestational diabetes mellitus: a systematic review and meta-analysis. Environmental Health. 21(1). 53–53. 64 indexed citations
9.
Yan, Dandan, et al.. (2022). Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer. BMC Cancer. 22(1). 1082–1082. 17 indexed citations
10.
Chen, Fangfang, Shuai Yin, Bin Luo, et al.. (2021). VDAC1 Conversely Correlates with Cytc Expression and Predicts Poor Prognosis in Human Breast Cancer Patients. Oxidative Medicine and Cellular Longevity. 2021(1). 7647139–7647139. 7 indexed citations
11.
Gao, Likun, Li Xu, Xiaokang Ke, et al.. (2021). Placental pathology of the third trimester pregnant women from COVID-19. Diagnostic Pathology. 16(1). 8–8. 42 indexed citations
12.
Wu, Xiaoyan, Chuang Chen, Bin Luo, et al.. (2021). Nuclear ING3 Expression Is Correlated With a Good Prognosis of Breast Cancer. Frontiers in Oncology. 10. 589009–589009. 10 indexed citations
13.
Zhang, Mingxin, Li Wang, Jia Wang, et al.. (2021). Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment. Journal of Gastrointestinal Oncology. 12(4). 1241–1254. 2 indexed citations
14.
Zeng, Zhi, Li Xu, Xiaoyu Xie, et al.. (2020). Pulmonary pathology of early‐phase COVID‐19 pneumonia in a patient with a benign lung lesion. Histopathology. 77(5). 823–831. 62 indexed citations
15.
Yan, Dandan, Chuang Chen, Honglin Yan, et al.. (2020). Mortality Risk After Radioiodine Therapy for Hyperthyroidism: A Systematic Review and Meta-Analysis. Endocrine Practice. 27(4). 362–369. 5 indexed citations
16.
Yuan, Jingping, et al.. (2019). Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients. Cancer Cell International. 19(1). 238–238. 35 indexed citations
17.
Zeng, Zhi, Lijuan Gu, Lin Liu, et al.. (2017). Myxoid adrenocortical adenoma with a pseudoglandular pattern: a case report and literature review.. PubMed. 10(8). 8908–8915. 1 indexed citations
18.
Yan, Honglin, et al.. (2016). Long noncoding RNA MEG3 activation of p53 mediates ischemic neuronal death in stroke. Neuroscience. 337. 191–199. 126 indexed citations
19.
Huang, Rui, Honglin Yan, Gui Ren, et al.. (2016). Comparison of O-Type HybridKnife to Conventional Knife in Endoscopic Submucosal Dissection for Gastric Mucosal Lesions. Medicine. 95(13). e3148–e3148. 14 indexed citations
20.
Yan, Honglin. (2005). Adjusted Refracturing Technology for Horizontal Seam in Daqing Oifield. Petroleum Geology & Oilfield Development in Daqing. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026